AYTU - Dinamika pendapatan YoY sajrone rolas wulan kepungkur Aytu BioPharma, Inc.

Logo grafis aytubio.com (AYTU)

Year-over-year sales growth (TTM) demonstrates the impact of DEA regulations on Adzenys production volumes for Aytu BioPharma, Inc. (AYTU). This trend relies on the efficiency of the sales force and insurance coverage across states, while the absence of pediatric analogs allows for flexible pricing power. The current business trajectory on this chart confirms revenue resilience, with the indicator value reaching -8.40.

AYTU Aytu BioPharma, Inc.: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 18.11.2026

Aytu BioPharma Inc (AYTU) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analitik perusahaan:AYTU (Aytu BioPharma Inc)
Produk seri Aytu BioPharma

Aytu BioPharma, Inc. (AYTU) is developing a diversified portfolio of drugs for the treatment of chronic and pediatric pathologies. Revenue dynamics here are calculated as the daily percentage change in total income over a rolling twelve-month period. This metric strips fundamental indicators of short-term volatility, revealing the actual resilience of the business model. The analysis allows for the determination of the company's true expansion vector. By assessing the year-over-year sales trend over the last 12 months, an investor eliminates market noise.

Analisis pesaing Aytu BioPharma, Inc.

VRTX (Vertex Pharmaceuticals Inc.) - Wutah dodolan taun lumaku|Alnylam Pharmaceuticals - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur INSM (Insmed Incorporated)|UTHR: Wutah dodolan YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur BridgeBio Pharma Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur BGM Group Ltd (BGM)|Wutah dodolan YoY sajrone rolas wulan kepungkur cogentbio.com (COGT)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Xeris Biopharma XERS|Wutah dodolan YoY (TTM) KROS (kerostx.com)|Wutah dodolan YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah dodolan YoY (TTM)|KMDA - Wutah dodolan YoY (TTM)|FULC (Fulcrum Corp) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ABEO (Abeona Therapeutics, Inc.) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY (TTM) PLRX|Wutah dodolan YoY sajrone rolas wulan kepungkur APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Gelteq Limited (GELS) - Wutah pendapatan taun lumaku|CMMB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku srxhealth.com|PLRZ (Polyrizon) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Aeterna Zentaris (AEZS) - Wutah dodolan YoY (TTM)|CYTH (Cyclo Therapeutics) - Wutah dodolan YoY (TTM)|INZY: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur